glucagonlike insulinotropic peptide

glucagonlike peptide (GLP-1),

a gut hormone that slows gastric emptying and stimulates insulin secretion. Its use has been posited in treatment of Type 2 diabetes mellitus, perhaps administered by patch, inhaler, or buccal pellet formulation.

glu·ca·gon·like in·su·li·no·tro·pic pep·tide

(GLIP) (glū'kă-gon-līk in'sū-lin-ō-trō'pik pep'tīd)
An insulinotropic substance originating in the gastrointestinal tract and released into the circulation following ingestion of a meal containing glucose.